Roche outlines plans to move towards autonomous AI labs

ZURICH, Sept 28 : Swiss pharmaceutical giant Roche outlined plans to move towards autonomous AI labs to speed up research and development discovery at its pharma investor day on Monday.Roche is committed to “AI independence” in R&D and has recently started building autonomous AI-driven labs, Aviv Regev, execu


Business

Roche outlines plans to move towards autonomous AI labs

Roche outlines plans to move towards autonomous AI labs

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

Read a summary of this article on FAST.

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

FAST

ZURICH, Sept 28 : Swiss pharmaceutical giant Roche outlined plans to move towards autonomous AI labs to speed up research and development discovery at its pharma investor day on Monday.

Roche is committed to “AI independence” in R&D and has recently started building autonomous AI-driven labs, Aviv Regev, executive vice president of Genentech Research and Early Development, said.

• About 2 billion Swiss francs ($2.41 billion) from R&D savings are set to be reallocated to programs and productivity initiatives by 2026, the company said

• By 2030 Roche aims to bring up to 20 new molecular entities (NMEs) to the market

Guess Word

Guess Word
Crack the word, one row at a time


Buzzword

Buzzword
Create words using the given letters


Mini Sudoku

Mini Sudoku
Tiny puzzle, mighty brain teaser


Mini Crossword

Mini Crossword
Small grid, big challenge


Word Search

Word Search
Spot as many words as you can


Show More


Show Less

• The company noted a jump in phase III success rate to >80 per cent in 2026 year-to-date from 65 per cent in 2025

• Regev said 40 per cent of pipeline decisions from the fourth quarter of 2025 through the second quarter of 2026 had a tracked AI and/or computational contribution

• The company said it is on track for its AI tool Target Nexus to contribute to 80 per cent of research portfolio decisions by the end of 2026

• Roche recently opened its Boston Innovation Center that will in part focus on applications of AI and machine learning in drug development

Source: Reuters

Sign up for our newsletters

Get our pick of top stories and thought-provoking articles in your inbox

Inbox

Get the CNA app

Stay updated with notifications for breaking news and our best stories

Get WhatsApp alerts

Join our channel for the top reads for the day on your preferred chat app

Whatsapp

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

FAST

Leave a Reply

Your email address will not be published. Required fields are marked *

About the Author

Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

BlockSpare — News, Magazine and Blog Addons for (Gutenberg) Block Editor

Search the Archives

Access over the years of investigative journalism and breaking reports